Table 3
Clinical findings of the 6 clear cell sarcomas analysed
| Case | Age (years) | Sex | Tumour site | Tumour size (cm) | RT-PCR | FISH | Follow up (months) | Outcome |
|---|---|---|---|---|---|---|---|---|
| AWD, alive with disease; CDF, continued disease free; DOD, died of disease; FISH, fluorescence in situ hybridisation; NA, data not available; ND, not detected; RT-PCR, reverse-transcription polymerase chain reaction. | ||||||||
| 1 | 25 | M | Thigh | 4.0 | EWS–ATF1 | Positive | 24 | AWD |
| 2 | 33 | M | Kidney | 12.0 | EWS–ATF1 | Positive | 8 | DOD |
| 3 | 38 | M | Abdominal wall | 6.0 | NA | Positive | 252 | DOD |
| 4 | 41 | M | Forearm | 4.5 | EWS–ATF1 | Positive | 6 | AWD |
| 5 | 62 | F | Ankle | 4.0 | EWS–ATF1 | ND | 20 | CDF |
| 6 | 69 | F | Hand | NA | EWS–ATF1 | Positive | 49 | DOD |
